In our in vitro study showed that nanaomycin K significantly inhibited tumor proliferation, invasion and migration via EMT in non-muscle invasive KK47 and muscle-invasive T24 cancer cells, especially in the presence of TGF-β. This evidence concerns the gene TGFB1 and neoplasm.